Repine; Joseph Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Repine; Joseph Thomas.The latest application filed is for "7-(4-(4-[3-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl)butoxy)-[1,8]-n- aphthyridin-2(1h)-one".

Company Profile

1.8.16

Repine; Joseph Thomas - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2-(pyridin-2-ylamino)-pyrido[2,3-D]pyrimidin-7-ones Grant RE47,739 - Barvian , et al. Nov	2019-11-26
2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones Grant 7,456,168 - Barvian , et al. November 25, 2	2008-11-25
7-(4-(4-[3-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl)butoxy)-[1,8]-n- Aphthyridin-2(1h)-one App 20080167319 - Favor; David Alan ; et al.	2008-07-10
2-(pyridin-2-ylamino)-pyrido [2,3 D]pyrimidin-7-ones App 20070179118 - Barvian; Mark ; et al.	2007-08-02
2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones Grant 7,208,489 - Barvian , et al. April 24, 2	2007-04-24
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia Grant 7,160,888 - Johnson , et al. January 9, 2	2007-01-09
[1,8]naphthyridin-2-ones And Related Compounds For The Treatment Of Schizophrenia App 20060287309 - Clark; Jerry D. ; et al.	2006-12-21
[1,8]naphthyridin-2-ones And Related Compounds For The Treatment Of Schizophrenia App 20060287310 - Clark; Jerry D. ; et al.	2006-12-21
Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia App 20060234997 - Favor; David ; et al.	2006-10-19
2-thia-1,6,8-triaza-naphthalene-2,2-dioxides are kinase inhibitors Grant 7,026,313 - Repine April 11, 2	2006-04-11
5-substituted tetralones as inhibitors of ras farnesyl transferase Grant 6,943,183 - Denny , et al. September 13, 2	2005-09-13
2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones Grant 6,936,612 - Barvian , et al. August 30, 2	2005-08-30
2-(Pyridin-2-ylamino)-pyrido [2,3-D]pyrimidin-7-ones App 20050137214 - Barvian, Mark ; et al.	2005-06-23
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia App 20050043309 - Clark, Jerry D. ; et al.	2005-02-24
2-Aminopyridine substituted heterocycles App 20040236084 - Biwersi, Cathlin Marie ; et al.	2004-11-25
Dihydro-2H-naphthalene-1-one inhibitors of ras farnesyl transferase App 20040171844 - Leonard, Daniele Marie ; et al.	2004-09-02
5- substituted tetralones as inhibitors of ras farnesyl trransferase App 20040044057 - Denny, William Alexander ; et al.	2004-03-04
Dihydro-2h-napthalene-1-one inhibitors of ras farnesyl transferase App 20030232790 - Leonard, Daniele Marie ; et al.	2003-12-18
2-Thia-1,6,8-Triaza-Naphthalene-2,2-Dioxides are kinase inhibitors App 20030186973 - Repine, Joseph Thomas	2003-10-02
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20030073684 - Bunker, Amy Mae ; et al.	2003-04-17
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20020094980 - Bunker, Amy Mae ; et al.	2002-07-18
Bicyclic inhibitors of protein farnesyl transferase App 20020006936 - Bikker, Jack ; et al.	2002-01-17
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20010036944 - Bunker, Amy Mae ; et al.	2001-11-01
Bicyclic inhibitors of protein farnesyl transferase Grant 6,133,303 - Bikker , et al. October 17, 2	2000-10-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.